| Trade Date |
Insider |
Title |
Buy or Sell |
Quantity |
Security Type |
Price |
Proceeds |
Transaction Conviction |
Position Quantity |
Position Value |
Positon Conviction |
SEC Link |
Nature of Ownership |
2020-07-01 | James Hollingshead | President, Sleep Business | Sell | 2,400 | ResMed Common Stock | $189.63 | $455,112.00 | - | 89,874 | $17,042,806.62 | - | Form 4 | - | 2020-07-06 | David Pendarvis | Chief Administrative Officer | Buy | 5,919 | ResMed Common Stock | $57.76 | -$341,881.44 | 0.41 [ Average ] | 139,861 | $8,078,371.36 | 9.67 [Average] | Form 4 | - | 2020-07-06 | David Pendarvis | Chief Administrative Officer | Sell | 5,919 | ResMed Common Stock | $194.64 | $1,152,074.16 | 0.41 [ Average ] | 133,942 | $26,070,470.88 | 9.26 [Average] | Form 4 | - | 2020-07-15 | Brett Sandercock | Chief Financial Officer | Sell | 2,500 | ResMed Common Stock | $196.98 | $492,450.00 | 0.17 [ Low ] | 84,796 | $16,703,116.08 | 5.86 [Average] | Form 4 | - | 2020-04-02 | James Hollingshead | President, Sleep Business | Sell | 1,200 | ResMed Common Stock | $150.00 | $180,000.00 | 0.08 [ Very Low ] | 94,565 | $14,184,750.00 | 6.54 [Average] | Form 4 | - | 2020-04-01 | Rajwant Sodhi | President, SaaS Business | Sell | 1,500 | ResMed Common Stock | $140.73 | $211,095.00 | 0.10 [ Low ] | 34,170 | $4,808,744.10 | 2.36 [Low] | Form 4 | - | 2020-04-03 | David Pendarvis | Chief Administrative Officer | Buy | 4,739 | ResMed Common Stock | $58.24 | -$275,999.36 | 0.33 [ Average ] | 135,303 | $7,880,046.72 | 9.35 [Average] | Form 4 | - | 2020-04-03 | David Pendarvis | Chief Administrative Officer | Sell | 4,739 | ResMed Common Stock | $152.63 | $723,313.57 | 0.33 [ Average ] | 130,564 | $19,927,983.32 | 9.03 [Average] | Form 4 | - | 2020-04-15 | Brett Sandercock | Chief Financial Officer | Sell | 2,500 | ResMed Common Stock | $159.03 | $397,575.00 | 0.17 [ Low ] | 92,211 | $14,664,315.33 | 6.37 [Average] | Form 4 | - | 2020-04-15 | Robert Andrew Douglas | President and COO ResMed Inc. | Sell | 1,222 | ResMed Common Stock | $159.03 | $194,334.66 | 0.08 [ Very Low ] | 189,216 | $30,091,020.48 | 13.08 [Average] | Form 4 | Douglas Family Trust | 2020-05-01 | James Hollingshead | President, Sleep Business | Sell | 1,200 | ResMed Common Stock | $164.00 | $196,800.00 | 0.08 [ Very Low ] | 93,365 | $15,311,860.00 | 6.45 [Average] | Form 4 | - | 2020-05-01 | Rajwant Sodhi | President, SaaS Business | Sell | 1,500 | ResMed Common Stock | $164.00 | $246,000.00 | 0.10 [ Low ] | 32,670 | $5,357,880.00 | 2.26 [Low] | Form 4 | - | 2020-05-04 | David Pendarvis | Chief Administrative Officer | Buy | 4,737 | ResMed Common Stock | $58.24 | -$275,882.88 | 0.33 [ Average ] | 135,379 | $7,884,472.96 | 9.36 [Average] | Form 4 | - | 2020-05-04 | David Pendarvis | Chief Administrative Officer | Sell | 4,737 | ResMed Common Stock | $155.06 | $734,519.22 | 0.33 [ Average ] | 130,642 | $20,257,348.52 | 9.03 [Average] | Form 4 | - | 2020-05-15 | Brett Sandercock | Chief Financial Officer | Sell | 2,500 | ResMed Common Stock | $162.05 | $405,125.00 | 0.17 [ Low ] | 89,796 | $14,551,441.80 | 6.21 [Average] | Form 4 | - | 2020-05-15 | Robert Andrew Douglas | President and COO ResMed Inc. | Sell | 1,228 | ResMed Common Stock | $162.05 | $198,997.40 | 0.08 [ Very Low ] | 187,988 | $30,463,455.40 | 12.99 [Average] | Form 4 | Douglas Family Trust | 2020-06-01 | David Pendarvis | Chief Administrative Officer | Sell | 239 | ResMed Common Stock | $161.12 | $38,507.68 | 0.02 [ Very Low ] | 130,403 | $21,010,531.36 | 9.01 [Average] | Form 4 | - | 2020-06-01 | James Hollingshead | President, Sleep Business | Sell | 1,200 | ResMed Common Stock | $160.13 | $192,156.00 | - | 92,274 | $14,775,835.62 | - | Form 4 | - | 2020-06-01 | Rajwant Sodhi | President, SaaS Business | Sell | 1,500 | ResMed Common Stock | $160.13 | $240,195.00 | - | 31,261 | $5,005,823.93 | - | Form 4 | - | 2020-06-03 | David Pendarvis | Chief Administrative Officer | Buy | 5,919 | ResMed Common Stock | $57.76 | -$341,881.44 | - | 136,322 | $7,873,958.72 | - | Form 4 | - | 2020-06-03 | David Pendarvis | Chief Administrative Officer | Sell | 5,919 | ResMed Common Stock | $160.61 | $950,650.59 | - | 130,403 | $20,944,025.83 | - | Form 4 | - | 2020-06-04 | David Pendarvis | Chief Administrative Officer | Buy | 7,022 | ResMed Common Stock | $160.82 | -$1,129,278.04 | - | 137,425 | $22,100,688.50 | - | Form 4 | - | 2020-06-04 | David Pendarvis | Chief Administrative Officer | Sell | 3,483 | ResMed Common Stock | $160.82 | $560,136.06 | - | 133,942 | $21,540,552.44 | - | Form 4 | - | 2020-06-15 | Robert Andrew Douglas | President and COO ResMed Inc. | Sell | 1,245 | ResMed Common Stock | $158.79 | $197,693.55 | 0.09 [ Very Low ] | 186,743 | $29,652,920.97 | 12.91 [Average] | Form 4 | Douglas Family Trust | 2020-06-15 | Brett Sandercock | Chief Financial Officer | Sell | 2,500 | ResMed Common Stock | $158.79 | $396,975.00 | 0.17 [ Low ] | 87,296 | $13,861,731.84 | 6.03 [Average] | Form 4 | - | 2020-07-15 | Robert Andrew Douglas | President and COO ResMed Inc. | Sell | 1,026 | ResMed Common Stock | $196.98 | $202,101.48 | 0.07 [ Very Low ] | 185,717 | $36,582,534.66 | 12.84 [Average] | Form 4 | Douglas Family Trust | 2020-08-03 | David Pendarvis | Chief Administrative Officer | Buy | 5,919 | ResMed Common Stock | $57.76 | -$341,881.44 | 0.41 [ Average ] | 139,081 | $8,033,318.56 | 9.61 [Average] | Form 4 | - | 2020-08-03 | David Pendarvis | Chief Administrative Officer | Sell | 5,919 | ResMed Common Stock | $201.99 | $1,195,578.81 | 0.41 [ Average ] | 133,162 | $26,897,392.38 | 9.20 [Average] | Form 4 | - | 2020-08-03 | James Hollingshead | President, Sleep Business | Sell | 2,400 | ResMed Common Stock | $202.02 | $484,848.00 | 0.17 [ Low ] | 87,474 | $17,671,497.48 | 6.05 [Average] | Form 4 | - | 2020-08-03 | Rajwant Sodhi | President, SaaS Business | Sell | 1,500 | ResMed Common Stock | $200.06 | $300,090.00 | 0.10 [ Low ] | 28,261 | $5,653,895.66 | 1.95 [Low] | Form 4 | - | 2020-08-13 | David Pendarvis | Chief Administrative Officer | Buy | 2,966 | ResMed Common Stock | $0.00 | $0.00 | - | 136,128 | $0.00 | 9.39 [Average] | Form 4 | - | 2020-08-13 | Brett Sandercock | Chief Financial Officer | Buy | 6,979 | ResMed Common Stock | $0.00 | $0.00 | - | 91,775 | $0.00 | 6.33 [Average] | Form 4 | - | 2020-08-13 | Michael J. Farrell | Chief Executive Officer | Buy | 13,435 | ResMed Common Stock | $0.00 | $0.00 | - | 368,173 | $0.00 | 25.41 [High] | Form 4 | - | 2020-08-13 | James Hollingshead | President, Sleep Business | Buy | 7,328 | ResMed Common Stock | $0.00 | $0.00 | - | 94,802 | $0.00 | 6.54 [Average] | Form 4 | - | 2020-08-13 | Rajwant Sodhi | President, SaaS Business | Buy | 7,328 | ResMed Common Stock | $0.00 | $0.00 | - | 35,589 | $0.00 | 2.46 [Low] | Form 4 | - | 2020-08-13 | Richard Mchale | President, RC Business | Buy | 5,235 | ResMed Common Stock | $0.00 | $0.00 | - | 22,982 | $0.00 | 1.59 [Low] | Form 4 | - | 2020-08-17 | Robert Andrew Douglas | President and COO ResMed Inc. | Sell | 1,132 | ResMed Common Stock | $177.55 | $200,986.60 | 0.08 [ Very Low ] | 184,585 | $32,773,066.75 | 12.74 [Average] | Form 4 | Douglas Family Trust | 2020-08-17 | Brett Sandercock | Chief Financial Officer | Sell | 2,500 | ResMed Common Stock | $177.55 | $443,875.00 | 0.17 [ Low ] | 89,275 | $15,850,776.25 | 6.16 [Average] | Form 4 | - | 2020-09-01 | James Hollingshead | President, Sleep Business | Sell | 2,400 | ResMed Common Stock | $202.02 | $484,848.00 | 0.17 [ Low ] | 92,402 | $18,667,052.04 | 6.38 [Average] | Form 4 | - | 2020-09-01 | Rajwant Sodhi | President, SaaS Business | Sell | 1,500 | ResMed Common Stock | $181.00 | $271,500.00 | 0.10 [ Low ] | 34,089 | $6,170,109.00 | 2.35 [Low] | Form 4 | - | 2020-09-03 | David Pendarvis | Chief Administrative Officer | Buy | 5,919 | ResMed Common Stock | $57.76 | -$341,881.44 | 0.41 [ Average ] | 142,047 | $8,204,634.72 | 9.80 [Average] | Form 4 | - | 2020-09-03 | David Pendarvis | Chief Administrative Officer | Sell | 5,919 | ResMed Common Stock | $177.52 | $1,050,740.88 | 0.41 [ Average ] | 136,128 | $24,165,442.56 | 9.39 [Average] | Form 4 | - | 2020-09-15 | Brett Sandercock | Chief Financial Officer | Sell | 2,500 | ResMed Common Stock | $175.49 | $438,725.00 | 0.17 [ Low ] | 86,775 | $15,228,144.75 | 5.99 [Average] | Form 4 | - | 2020-09-15 | Robert Andrew Douglas | President and COO ResMed Inc. | Sell | 1,147 | ResMed Common Stock | $175.49 | $201,287.03 | 0.08 [ Very Low ] | 183,438 | $32,191,534.62 | 12.66 [Average] | Form 4 | Douglas Family Trust | 2020-10-01 | James Hollingshead | President, Sleep Business | Sell | 2,400 | ResMed Common Stock | $170.43 | $409,032.00 | 0.17 [ Low ] | 90,002 | $15,339,040.86 | 6.21 [Average] | Form 4 | - | 2020-10-01 | Rajwant Sodhi | President, SaaS Business | Sell | 1,500 | ResMed Common Stock | $172.84 | $259,260.00 | 0.10 [ Low ] | 32,589 | $5,632,682.76 | 2.25 [Low] | Form 4 | - | 2020-10-05 | David Pendarvis | Chief Administrative Officer | Buy | 5,919 | ResMed Common Stock | $57.76 | -$341,881.44 | 0.41 [ Average ] | 142,047 | $8,204,634.72 | 9.80 [Average] | Form 4 | - | 2020-10-05 | David Pendarvis | Chief Administrative Officer | Sell | 5,919 | ResMed Common Stock | $170.07 | $1,006,644.33 | 0.41 [ Average ] | 136,128 | $23,151,288.96 | 9.39 [Average] | Form 4 | - | 2020-10-15 | Brett Sandercock | Chief Financial Officer | Sell | 2,500 | ResMed Common Stock | $176.72 | $441,800.00 | 0.17 [ Low ] | 84,275 | $14,893,078.00 | 5.82 [Average] | Form 4 | - | 2020-10-15 | Robert Andrew Douglas | President and COO ResMed Inc. | Sell | 1,125 | ResMed Common Stock | $176.72 | $198,810.00 | 0.08 [ Very Low ] | 182,313 | $32,218,353.36 | 12.58 [Average] | Form 4 | Douglas Family Trust | 2020-11-02 | Carol Burt | - | Sell | 263 | ResMed Common Stock | $0.00 | $0.00 | - | 13,215 | $0.00 | 0.91 [Very Low] | Form 4 | Carol Burt Hilliard Trust | 2020-11-02 | James Hollingshead | President, Sleep Business | Sell | 2,400 | ResMed Common Stock | $195.00 | $468,000.00 | 0.17 [ Low ] | 87,602 | $17,082,390.00 | 6.05 [Average] | Form 4 | - | 2020-11-02 | Rajwant Sodhi | President, SaaS Business | Sell | 1,500 | ResMed Common Stock | $195.16 | $292,740.00 | 0.10 [ Low ] | 31,089 | $6,067,329.24 | 2.15 [Low] | Form 4 | - | 2020-11-03 | David Pendarvis | Chief Administrative Officer | Buy | 5,918 | ResMed Common Stock | $57.76 | -$341,823.68 | 0.41 [ Average ] | 142,046 | $8,204,576.96 | 9.80 [Average] | Form 4 | - | 2020-11-03 | David Pendarvis | Chief Administrative Officer | Sell | 5,918 | ResMed Common Stock | $201.14 | $1,190,346.52 | 0.41 [ Average ] | 136,128 | $27,380,785.92 | 9.39 [Average] | Form 4 | - | 2020-11-11 | Peter C Farrell | - | Sell | 579 | ResMed Common Stock | $212.11 | $122,811.69 | 0.04 [ Very Low ] | 227,449 | $48,244,207.39 | 15.70 [Average] | Form 4 | - | 2020-11-11 | David Pendarvis | Chief Administrative Officer | Sell | 855 | ResMed Common Stock | $212.11 | $181,354.05 | 0.06 [ Very Low ] | 135,352 | $28,709,512.72 | 9.34 [Average] | Form 4 | - | 2020-11-11 | David Pendarvis | Chief Administrative Officer | Sell | 722 | ResMed Common Stock | $212.11 | $153,143.42 | 0.05 [ Very Low ] | 134,630 | $28,556,369.30 | 9.29 [Average] | Form 4 | - | 2020-11-11 | David Pendarvis | Chief Administrative Officer | Sell | 490 | ResMed Common Stock | $212.11 | $103,933.90 | 0.03 [ Very Low ] | 134,140 | $28,452,435.40 | 9.26 [Average] | Form 4 | - | 2020-11-11 | Robert Andrew Douglas | President and COO ResMed Inc. | Sell | 1,717 | ResMed Common Stock | $212.11 | $364,192.87 | 0.12 [ Low ] | 22,981 | $4,874,499.91 | 1.59 [Low] | Form 4 | - | 2020-11-11 | Michael J. Farrell | Chief Executive Officer | Sell | 3,417 | ResMed Common Stock | $212.11 | $724,779.87 | 0.24 [ Low ] | 364,878 | $77,394,272.58 | 25.18 [High] | Form 4 | - | 2020-11-11 | Michael J. Farrell | Chief Executive Officer | Sell | 2,973 | ResMed Common Stock | $212.11 | $630,603.03 | 0.21 [ Low ] | 361,905 | $76,763,669.55 | 24.97 [High] | Form 4 | - | 2020-11-11 | Michael J. Farrell | Chief Executive Officer | Sell | 2,221 | ResMed Common Stock | $212.11 | $471,096.31 | 0.15 [ Low ] | 359,684 | $76,292,573.24 | 24.82 [High] | Form 4 | - | 2020-11-11 | James Hollingshead | President, Sleep Business | Sell | 2,135 | ResMed Common Stock | $212.11 | $452,854.85 | 0.15 [ Low ] | 85,524 | $18,140,495.64 | 5.90 [Average] | Form 4 | - | 2020-11-11 | James Hollingshead | President, Sleep Business | Sell | 1,804 | ResMed Common Stock | $212.11 | $382,646.44 | 0.12 [ Low ] | 83,720 | $17,757,849.20 | 5.78 [Average] | Form 4 | - | 2020-11-11 | James Hollingshead | President, Sleep Business | Sell | 1,286 | ResMed Common Stock | $212.11 | $272,773.46 | 0.09 [ Very Low ] | 82,434 | $17,485,075.74 | 5.69 [Average] | Form 4 | - | 2020-11-11 | Rajwant Sodhi | President, SaaS Business | Sell | 982 | ResMed Common Stock | $212.11 | $208,292.02 | 0.07 [ Very Low ] | 30,180 | $6,401,479.80 | 2.08 [Low] | Form 4 | - | 2020-11-11 | Rajwant Sodhi | President, SaaS Business | Sell | 1,418 | ResMed Common Stock | $212.11 | $300,771.98 | 0.10 [ Low ] | 28,762 | $6,100,707.82 | 1.98 [Low] | Form 4 | - | 2020-11-11 | Rajwant Sodhi | President, SaaS Business | Sell | 1,211 | ResMed Common Stock | $212.11 | $256,865.21 | 0.08 [ Very Low ] | 27,551 | $5,843,842.61 | 1.90 [Low] | Form 4 | - | 2020-11-05 | Justin Leong | President, Asia Latin America | Buy | 7,740 | ReMed Common Stock | $57.76 | -$447,062.40 | 0.53 [ Average ] | 33,126 | $1,913,357.76 | 2.29 [Low] | Form 4 | - | 2020-11-05 | Justin Leong | President, Asia Latin America | Sell | 7,740 | ReMed Common Stock | $211.36 | $1,635,926.40 | 0.53 [ Average ] | 25,386 | $5,365,584.96 | 1.75 [Low] | Form 4 | - | 2020-11-19 | Ronald R Taylor | - | Buy | 1,187 | ResMed Common Stock | $0.00 | $0.00 | - | 22,769 | $0.00 | 1.57 [Low] | Form 4 | - | 2020-11-19 | Peter C Farrell | - | Buy | 1,187 | ResMed Common Stock | $0.00 | $0.00 | - | 228,636 | $0.00 | 15.78 [Average] | Form 4 | - | 2020-11-19 | Richard Sulpizio | - | Buy | 1,187 | ResMed Common Stock | $0.00 | $0.00 | - | 12,867 | $0.00 | 0.89 [Very Low] | Form 4 | - | 2020-11-19 | Carol Burt | - | Buy | 1,187 | ResMed Common Stock | $0.00 | $0.00 | - | 2,914 | $0.00 | 0.20 [Very Low] | Form 4 | - | 2020-11-19 | Karen Drexler | - | Buy | 594 | ResMed Common Stock | $0.00 | $0.00 | - | 6,981 | $0.00 | 0.48 [Very Low] | Form 4 | - | 2020-11-19 | Harjit Gill | - | Buy | 1,187 | ResMed Common Stock | $0.00 | $0.00 | - | 5,345 | $0.00 | 0.37 [Very Low] | Form 4 | - | 2020-11-19 | Witte Jan De | - | Buy | 1,187 | ReMed Common Stock | $0.00 | $0.00 | - | 4,320 | $0.00 | 0.30 [Very Low] | Form 4 | - | 2020-11-20 | David Pendarvis | Chief Administrative Officer | Buy | 1,176 | ResMed Common Stock | $84.98 | -$99,936.48 | 0.08 [ Very Low ] | 145,181 | $12,337,481.38 | 10.02 [Average] | Form 4 | - | 2020-11-23 | David Pendarvis | Chief Administrative Officer | Sell | 10,000 | ResMed Common Stock | $0.00 | $0.00 | - | 135,181 | $0.00 | 9.33 [Average] | Form 4 | - | 2020-11-24 | Brett Sandercock | Chief Financial Officer | Sell | 5,000 | ResMed Common Stock | $211.00 | $1,055,000.00 | 0.35 [ Average ] | 105,600 | $22,281,600.00 | 7.29 [Average] | Form 4 | - | 2020-11-24 | Robert Andrew Douglas | President and COO ResMed Inc. | Sell | 955 | ResMed Common Stock | $211.00 | $201,505.00 | 0.07 [ Very Low ] | 215,836 | $45,541,396.00 | 14.89 [Average] | Form 4 | Douglas Family Trust | 2020-11-24 | Robert Andrew Douglas | President and COO ResMed Inc. | Sell | 478 | ResMed Common Stock | $0.00 | $0.00 | - | 215,358 | $0.00 | 14.86 [Average] | Form 4 | Douglas Family Trust | 2020-11-27 | Harjit Gill | - | Sell | 116 | ResMed Common Stock | $212.11 | $24,604.76 | - | 5,229 | $1,109,123.19 | 0.36 [Very Low] | Form 4 | - | 2020-11-27 | Witte Jan De | - | Sell | 183 | ReMed Common Stock | $212.11 | $38,816.13 | - | 4,137 | $877,499.07 | 0.29 [Very Low] | Form 4 | - | 2020-12-01 | James Hollingshead | President, Sleep Business | Sell | 2,400 | ResMed Common Stock | $210.97 | $506,328.00 | 0.17 [ Low ] | 90,733 | $19,141,941.01 | 6.26 [Average] | Form 4 | - | 2020-12-01 | Rajwant Sodhi | President, SaaS Business | Sell | 1,500 | ResMed Common Stock | $210.46 | $315,690.00 | 0.10 [ Low ] | 34,175 | $7,192,470.50 | 2.36 [Low] | Form 4 | - | 2020-12-03 | David Pendarvis | Chief Administrative Officer | Sell | 1,487 | ResMed Common Stock | $208.36 | $309,831.32 | 0.10 [ Low ] | 133,694 | $27,856,481.84 | 9.23 [Average] | Form 4 | - | 2020-12-10 | Brett Sandercock | Chief Financial Officer | Sell | 2,500 | ResMed Common Stock | $211.06 | $527,650.00 | 0.17 [ Low ] | 103,100 | $21,760,286.00 | 7.11 [Average] | Form 4 | - | 2020-12-15 | Robert Andrew Douglas | President and COO ResMed Inc. | Sell | 970 | ResMed Common Stock | $207.80 | $201,566.00 | 0.07 [ Very Low ] | 214,388 | $44,549,826.40 | 14.79 [Average] | Form 4 | Douglas Family Trust | 2021-01-04 | David Pendarvis | Chief Administrative Officer | Sell | 1,487 | ResMed Common Stock | $213.24 | $317,087.88 | 0.10 [ Very Low ] | 132,207 | $28,191,820.68 | 9.12 [Average] | Form 4 | - | 2021-01-04 | James Hollingshead | President, Sleep Business | Sell | 2,400 | ResMed Common Stock | $211.09 | $506,616.00 | 0.17 [ Low ] | 88,333 | $18,646,212.97 | 6.10 [Average] | Form 4 | - | 2021-01-04 | Rajwant Sodhi | President, SaaS Business | Sell | 1,500 | ResMed Common Stock | $213.24 | $319,860.00 | 0.10 [ Very Low ] | 32,675 | $6,967,617.00 | 2.25 [Low] | Form 4 | - | 2021-01-11 | Brett Sandercock | Chief Financial Officer | Sell | 2,500 | ResMed Common Stock | $218.70 | $546,750.00 | 0.17 [ Low ] | 100,600 | $22,001,220.00 | 6.94 [Average] | Form 4 | - | 2021-01-18 | David Pendarvis | Chief Administrative Officer | Buy | 1,548 | ResMed Common Stock | $0.00 | $0.00 | - | 133,755 | $0.00 | 9.23 [Average] | Form 4 | - | 2021-01-18 | Brett Sandercock | Chief Financial Officer | Buy | 1,822 | ResMed Common Stock | $0.00 | $0.00 | - | 102,422 | $0.00 | 7.07 [Average] | Form 4 | - | 2021-01-15 | Robert Andrew Douglas | President and COO ResMed Inc. | Sell | 938 | ResMed Common Stock | $212.86 | $199,662.68 | 0.06 [ Very Low ] | 213,450 | $45,434,967.00 | 14.73 [Average] | Form 4 | Douglas Family Trust | 2021-01-18 | Robert Andrew Douglas | President and COO ResMed Inc. | Buy | 4,099 | ResMed Common Stock | $0.00 | $0.00 | - | 16,701 | $0.00 | 1.15 [Very Low] | Form 4 | - | 2021-01-18 | Michael J. Farrell | Chief Executive Officer | Buy | 7,014 | ResMed Common Stock | $0.00 | $0.00 | - | 406,160 | $0.00 | 28.03 [High] | Form 4 | - | 2021-01-18 | James Hollingshead | President, Sleep Business | Buy | 1,913 | ResMed Common Stock | $0.00 | $0.00 | - | 90,246 | $0.00 | 6.23 [Average] | Form 4 | - | 2021-01-18 | Rajwant Sodhi | President, SaaS Business | Buy | 1,913 | ResMed Common Stock | $0.00 | $0.00 | - | 34,588 | $0.00 | 2.39 [Low] | Form 4 | - | 2021-01-18 | Justin Leong | President, Asia Latin America | Buy | 865 | ReMed Common Stock | $0.00 | $0.00 | - | 38,064 | $0.00 | 2.63 [Low] | Form 4 | - | 2021-02-01 | James Hollingshead | President, Sleep Business | Sell | 2,400 | ResMed Common Stock | $200.18 | $480,432.00 | 0.16 [ Low ] | 87,846 | $17,585,012.28 | 6.04 [Average] | Form 4 | - | 2021-02-01 | Rajwant Sodhi | President, SaaS Business | Sell | 1,500 | ResMed Common Stock | $203.76 | $305,640.00 | 0.10 [ Low ] | 33,088 | $6,742,010.88 | 2.27 [Low] | Form 4 | - | 2021-02-03 | David Pendarvis | Chief Administrative Officer | Sell | 1,487 | ResMed Common Stock | $204.42 | $303,972.54 | 0.10 [ Low ] | 132,268 | $27,038,224.56 | 9.09 [Average] | Form 4 | - | 2021-02-10 | Brett Sandercock | Chief Financial Officer | Sell | 2,500 | ResMed Common Stock | $201.37 | $503,425.00 | 0.17 [ Low ] | 99,922 | $20,121,293.14 | 6.87 [Average] | Form 4 | - | 2021-02-16 | Robert Andrew Douglas | President and COO ResMed Inc. | Sell | 998 | ResMed Common Stock | $200.46 | $200,059.08 | 0.07 [ Very Low ] | 212,452 | $42,588,127.92 | 14.60 [Average] | Form 4 | Douglas Family Trust | 2021-02-19 | Ronald R Taylor | - | Sell | 4,000 | ResMed Common Stock | $200.14 | $800,560.00 | 0.27 [ Low ] | 18,769 | $3,756,427.66 | 1.29 [Low] | Form 4 | - |
